Plonmarlimab, a novel anti‐GM‐CSF blocking antibody, ameliorates disease progression in the pre‐clinical model of macrophage activation syndrome.
Saved in:
| Title: | Plonmarlimab, a novel anti‐GM‐CSF blocking antibody, ameliorates disease progression in the pre‐clinical model of macrophage activation syndrome. |
|---|---|
| Authors: | Ding, Jian1 (AUTHOR), Xu, Ke1 (AUTHOR), Niu, Yanling1 (AUTHOR), Qin, Yihui1 (AUTHOR), Shen, Hong2 (AUTHOR), Wang, Yajuan1 (AUTHOR), Guo, Wenyu1 (AUTHOR), Liu, Xuejun1 (AUTHOR), Wang, Zhengyi1 (AUTHOR), Zhu, Andrew X.1 (AUTHOR) andrew.zhu@tjbio.com |
| Source: | Immunology. Nov2024, Vol. 173 Issue 3, p552-561. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 180109350 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Plonmarlimab, a novel anti‐GM‐CSF blocking antibody, ameliorates disease progression in the pre‐clinical model of macrophage activation syndrome. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Ding%2C+Jian%22">Ding, Jian</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Ke%22">Xu, Ke</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Niu%2C+Yanling%22">Niu, Yanling</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qin%2C+Yihui%22">Qin, Yihui</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shen%2C+Hong%22">Shen, Hong</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Yajuan%22">Wang, Yajuan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guo%2C+Wenyu%22">Guo, Wenyu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Xuejun%22">Liu, Xuejun</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Zhengyi%22">Wang, Zhengyi</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhu%2C+Andrew+X%2E%22">Zhu, Andrew X.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> andrew.zhu@tjbio.com</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Immunology%22">Immunology</searchLink>. Nov2024, Vol. 173 Issue 3, p552-561. 10p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=180109350 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/imm.13842 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 552 Titles: – TitleFull: Plonmarlimab, a novel anti‐GM‐CSF blocking antibody, ameliorates disease progression in the pre‐clinical model of macrophage activation syndrome. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ding, Jian – PersonEntity: Name: NameFull: Xu, Ke – PersonEntity: Name: NameFull: Niu, Yanling – PersonEntity: Name: NameFull: Qin, Yihui – PersonEntity: Name: NameFull: Shen, Hong – PersonEntity: Name: NameFull: Wang, Yajuan – PersonEntity: Name: NameFull: Guo, Wenyu – PersonEntity: Name: NameFull: Liu, Xuejun – PersonEntity: Name: NameFull: Wang, Zhengyi – PersonEntity: Name: NameFull: Zhu, Andrew X. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 00192805 Numbering: – Type: volume Value: 173 – Type: issue Value: 3 Titles: – TitleFull: Immunology Type: main |
| ResultId | 1 |
